Buscar resultados de ensayos clínicos
Leukemia-Lymphoma, Adult T-Cell - 25 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Evaluation and Treatment of Tall Statured Girls Condición: Constitutional Tall Stature Fecha: 2015-12-13 Intervenciones: Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
Completed |
Nombre del estudio: A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma Condición:
Fecha: 2010-07-22 Intervenciones: Drug: Lenalidomide Lenalidomide: 25mg daily on day 1-21 of each 28days cycle (1st cohort), 25 mg daily o |
Completed |
Nombre del estudio: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) Condición: T-ALL, T-NHL (Lymphoblastic) Fecha: 2008-05-16 Intervenciones: Drug: Nelarabine 1500 mg/m² i.v., duration 2 hrs, day 1, 3, 5 |
Completed |
Nombre del estudio: EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma Condición: Leukemia-Lymphoma, Adult T-Cell Fecha: 2009-10-19 Intervenciones:
|
Recruiting |
Nombre del estudio: Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) Condición:
|
Completed |
Nombre del estudio: Multicenter, Randomized, Open-label, Parallel-group Study to Compare mLSG15 + KW-0761 to mLSG15 Condición: Adult T-cell Leukemia-Lymphoma Fecha: 2010-07-30 Intervenciones:
|
Completed |
Nombre del estudio: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Condición: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Fecha: 2011-08-16 Intervenciones: Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Completed |
Nombre del estudio: Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load Condición: Human T-cell Leukemia Virus Type 1 Infection Fecha: 2012-01-25 Intervenciones: Drug: Raltegravir Raltegravir 400 mg po bid |
Completed |
Nombre del estudio: Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL Condición:
|
Recruiting |
Nombre del estudio: Ruxolitinib for Adult T-Cell Leukemia Condición:
|